251 related articles for article (PubMed ID: 18614916)
1. Effect of HAART on incident cancer and noncancer AIDS events among male HIV seroconverters.
Shiels MS; Cole SR; Wegner S; Armenian H; Chmiel JS; Ganesan A; Marconi VC; Martinez-Maza O; Martinson J; Weintrob A; Jacobson LP; Crum-Cianflone NF
J Acquir Immune Defic Syndr; 2008 Aug; 48(4):485-90. PubMed ID: 18614916
[TBL] [Abstract][Full Text] [Related]
2. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
3. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.
Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK
J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086
[TBL] [Abstract][Full Text] [Related]
4. A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men.
Shiels MS; Cole SR; Chmiel JS; Margolick J; Martinson J; Zhang ZF; Jacobson LP
J Clin Epidemiol; 2010 Apr; 63(4):459-67. PubMed ID: 19880284
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.
Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP;
Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
7. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
International Collaboration on HIV and Cancer
J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
[TBL] [Abstract][Full Text] [Related]
8. AIDS-related cancer and severity of immunosuppression in persons with AIDS.
Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA;
J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153
[TBL] [Abstract][Full Text] [Related]
9. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.
Schwarcz L; Chen MJ; Vittinghoff E; Hsu L; Schwarcz S
AIDS; 2013 Feb; 27(4):597-605. PubMed ID: 23079812
[TBL] [Abstract][Full Text] [Related]
10. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.
Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217
[TBL] [Abstract][Full Text] [Related]
11. Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters.
Cain LE; Cole SR; Chmiel JS; Margolick JB; Rinaldo CR; Detels R
Am J Epidemiol; 2006 Feb; 163(4):310-5. PubMed ID: 16371516
[TBL] [Abstract][Full Text] [Related]
12. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
13. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
[TBL] [Abstract][Full Text] [Related]
14. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
15. Long-term cancer risk among people diagnosed with AIDS during childhood.
Simard EP; Shiels MS; Bhatia K; Engels EA
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):148-54. PubMed ID: 22068287
[TBL] [Abstract][Full Text] [Related]
16. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
Tserenpuntsag B; Kołacińska A; Jabłonowska E
Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
[TBL] [Abstract][Full Text] [Related]
17. Cancer in HIV-infected persons from the Caribbean, Central and South America.
Fink VI; Shepherd BE; Cesar C; Krolewiecki A; Wehbe F; Cortés CP; Crabtree-Ramírez B; Padgett D; Shafaee M; Schechter M; Gotuzzo E; Bacon M; McGowan C; Cahn P; Masys D;
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):467-73. PubMed ID: 21239992
[TBL] [Abstract][Full Text] [Related]
18. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
[TBL] [Abstract][Full Text] [Related]
19. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
Franceschi S; Lise M; Clifford GM; Rickenbach M; Levi F; Maspoli M; Bouchardy C; Dehler S; Jundt G; Ess S; Bordoni A; Konzelmann I; Frick H; Dal Maso L; Elzi L; Furrer H; Calmy A; Cavassini M; Ledergerber B; Keiser O;
Br J Cancer; 2010 Jul; 103(3):416-22. PubMed ID: 20588274
[TBL] [Abstract][Full Text] [Related]
20. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]